Kjd Pharma Private Limited - Due diligence report

A 360° intelligence report on Kjd Pharma Private Limited: trust score, financial health, credit view, compliance, directors, growth and dist…

2014-03-25 Bidar, Karnataka Active Unlisted Active Compliant
Share
Connect MCP
KP Kjd Pharma Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Kjd Pharma Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
61/100
Trust Score
Moderate

Kjd Pharma Private Limited is assessed as Moderate with a Trust Score of 61/100. Kjd Pharma Private Limited is an active private limited indian non-government company incorporated in 2014, operating in the Pharma sector. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and high financial risk profile.

Report generated on 01 Oct 2026 from the latest processed filings. Kjd Pharma Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
61/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
68/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
20/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
60/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
55/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 4 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.

Charges position: 0 open (-) · 1 satisfied (13.00 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Canara Bank1 48.0 cr
Compliance Score: 68/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
  • Litigation present in 3 court forum(s).
  • 1 active GST registration(s).
Legal cases on record (3)
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
SHANKER DASHARATHRAO KOTARKI 01234567 Director 01/04/2018 6 yrs Approved
Venkata Rama Rao Kovoor 01234567 Director 01/04/2018 6 yrs Approved
Sivaramakrishnareddy Pathuri 01234567 Director 01/04/2018 6 yrs Approved
DEEPAK JOSHI 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • No disqualified or deactivated DINs.
  • 2 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2019 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
6 allotment(s) · 0 transfer(s)

Promoters hold a majority stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 60 · Distress 55
Growth signals & trust indicators
Latest year revenue grew 38%.
Operating for 12+ years.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
Negative net worth.
3 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence62/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment43/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view46/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
29 Sep 2024
Director ceased
Venkata Rama Rao Kovoor
Director ceased
Sivaramakrishnareddy Pathuri
26 Aug 2024
Charge satisfied
Canara Bank
26 Apr 2024
Director appointed
Venkata Rama Rao Kovoor (Director)
Director appointed
Sivaramakrishnareddy Pathuri (Director)
08 Apr 2019
Securities allotted
1852400 Equity Shares Without Differential Rights - 1.85 cr raised
11 Feb 2019
Securities allotted
1852400 Equity Shares Without Differential Rights - 1.85 cr raised
01 Dec 2017
Securities allotted
210000 Equity Shares With Differential Rights - 42.00 Lakh raised
Securities allotted
1927600 Equity Shares With Differential Rights - 1.93 cr raised
31 Mar 2017
Securities allotted
210000 Equity Shares With Differential Rights - 42.00 Lakh raised
Securities allotted
1927600 Equity Shares With Differential Rights - 1.93 cr raised
30 Sep 2015
Charge created
Canara Bank - 13.00 cr
25 Mar 2014
Incorporated
Registered with Roc Bangalore
10

Key Observations

Auto-generated from the data above
4 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
All 1 registered charge(s) stand satisfied - past borrowings repaid.
Promoters hold a majority stake as per the FY 2019 annual return.
Capital has been raised through 6 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Patwa Abhikaran Ratlam Pvt. Ltd. U50103MP1989PTC005445 Ratlam, Madhya Pradesh, India
Clay Club Innovations Private Limited U36999GJ2013PTC073977 Ahmedabad, Gujarat, India
Shree Ram Glass Agencies Private Limited U26100BR1997PTC008060 Patna, Bihar, India
Mallika Textiles Private Limited U17299PB2012PTC036789 Ludhiana, Punjab, India
Dakshin Kaolin Products Private Limited U14108KL1997PTC011597 Trivandrum, Kerala, India
Aapss Stationery Products Private Limited U74999DL2017PTC316070 New Delhi, Delhi, India
Pavithra Building Material Suppliers Private Limited U51909TG2018PTC122970 Old Alwal Secunderabad, Telangana, India
Telemetra Systems Private Limited U99999PN1987PTC045075 Pune, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Kjd Pharma Private Limited before audits and certifications: compliance score 68/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Kjd Pharma Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 60/100, margin trends, ownership structure and peer set for Kjd Pharma Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 61/100, distress signals and MSME payment-delay disclosures - know whether Kjd Pharma Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Kjd Pharma Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Kjd Pharma Private Limited an active company?

Kjd Pharma Private Limited has MCA status “Active” with a compliance score of 68/100 (Moderate).

Is Kjd Pharma Private Limited financially healthy?

Kjd Pharma Private Limited has a Financial Health Score of 20/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Kjd Pharma Private Limited?

Its overall Trust Score is 61/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Kjd Pharma Private Limited?

Promoters hold a majority stake - exact percentages are in the full report. 4 active director(s) are on record.

Does Kjd Pharma Private Limited have loans or charges against its assets?

No open charges - all 1 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Kjd Pharma Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 68/100 (Moderate).

Is it risky to lend to Kjd Pharma Private Limited?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.